Sir John Stuart Lilleyman FRCP FRCPE FRCPCH FMedSci (born 9 July 1945) is a British paediatric haematologist.[1] His specialization is childhood leukemia and idiopathic thrombocytopenic purpura.[2]

Career edit

Lilleyman contributed to the testing of leukemia treatment methods and conducted research on "thiopurine metabolism" in children with leukemia.[2]

He was president of the Royal College of Pathologists during the Alder Hey organs scandal.[2] During that time, he was vice-chairman of the Academy of the Medical Royal Colleges.[2]

In 2004, he became medical director of the National Patient Safety Agency (NPSA).[3]

Awards and honours edit

In 1991, the Royal College of Pathologists awarded him its first Distinguished Service Medal for establishing the United Kingdom's system of pathology laboratory accreditation.[4] He was appointed president of the Royal Society of Medicine in 2004.[3]

Selected publications edit

Books edit

  • John S. Lilleyman (1992)Paediatric Haematology. Publisher: Churchill Livingstone (1 November 1992). ISBN 0443043663
  • John S. Lilleyman (1994). Childhood Leukaemia: The Facts (The Facts Series). Publisher: Oxford University Press (25 August 1994). ISBN 0192624512
  • John S. Lilleyman (1999). Pediatric Hematology, 2e. Publisher: Churchill Livingstone; 2 edition (11 May 1999) ISBN 0443058407

References edit

  1. ^ "Lilleyman, Sir John (Stuart)". Who's Who. A & C Black. doi:10.1093/ww/9780199540884.013.U41652. (Subscription or UK public library membership required.)
  2. ^ a b c d "Sir John Lilleyman". acmedsci.ac.uk. Archived from the original on 1 July 2023. Retrieved 1 July 2023.
  3. ^ a b Sanai, Leyla (2006). "Professor Sir John Lilleyman". Career Focus. British Medical Journal. 332 (7536): s50. doi:10.1136/bmj.332.7536.s50.
  4. ^ "-John Lilleyman: Editor 1986-1992". Journal of Clinical Pathology. 46 (1): 1. 1993. doi:10.1136/jcp.46.1.1. PMC 501088. PMID 16811188.

External links edit

Educational offices
Preceded by President of the Royal College of Pathologists
1999 – 2002
Succeeded by